Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol–levonorgestrel in healthy adults.

MLA

Lin, Swan, et al. “Effects of the Selective AMPA Modulator NBI‐1065845 on the Pharmacokinetics of Midazolam or Ethinyl Estradiol–levonorgestrel in Healthy Adults.” CTS: Clinical & Translational Science, vol. 17, no. 5, May 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1111/cts.13791.

APA

Lin, S., Ionescu, A., Maynard, S. J., Kennedy, M., Walling, D. P., Furey, M., & Singh, J. B. (2024). Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol–levonorgestrel in healthy adults. CTS: Clinical & Translational Science, 17(5), 1–10. https://doi.org/10.1111/cts.13791

Chicago

Lin, Swan, Adrian Ionescu, Scott, Jessica Maynard, Mike Kennedy, David P. Walling, Maura Furey, and Jaskaran B. Singh. 2024. “Effects of the Selective AMPA Modulator NBI‐1065845 on the Pharmacokinetics of Midazolam or Ethinyl Estradiol–levonorgestrel in Healthy Adults.” CTS: Clinical & Translational Science 17 (5): 1–10. doi:10.1111/cts.13791.